← All companies

BRTX

BioRestorative Therapies, Inc.

BRTX Nasdaq Services-Misc Health & Allied Services, NEC EDGAR ↗

$0.20

-0.03 -12.24%

Key statistics

from XBRL data in SEC filings

Market cap

$5.04M

Revenue (TTM)

$358K

Net income (TTM)

-$11.1M

EPS (TTM)

$-1.06

P/E ratio

—

Dividend yield

—

Free cash flow

-$10.9M

Cash

$3.11M

Total assets

$4.64M

Gross margin

92.1%

52-week range

$0.16 – $1.89

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 16, 2026 8-K Director or officer change Jun 12, 2026 8-K Entered a material agreement; Director or officer change Jun 12, 2026 8-K Director or officer change; Shareholder vote results May 29, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Director or officer change May 1, 2026 8-K Regulation FD disclosure Apr 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Entered a material agreement; Regulation FD disclosure Feb 17, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 8, 2025 8-K Shareholder vote results Sep 25, 2025 8-K Regulation FD disclosure Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Regulation FD disclosure Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2025 8-K Changed accountants Apr 21, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2025 8-K Regulation FD disclosure Feb 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Regulation FD disclosure Nov 7, 2024 8-K Entered a material agreement; Terminated a material agreement Nov 6, 2024 10-K/A Fiscal year ended 2023-12-31 Nov 6, 2024 8-K Shareholder vote results Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2024 10-Q Quarter ended 2024-03-31 Jun 11, 2024 10-K/A Fiscal year ended 2023-12-31 Jun 11, 2024 8-K Delisting notice or listing-rule failure May 24, 2024 8-K Previously issued financials not reliable May 24, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Regulation FD disclosure Mar 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Feb 8, 2024 8-K Regulation FD disclosure Feb 5, 2024